Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

Abstract P5-13-03: The Influences of Co-Morbidities and Age on Risk of Death without Recurrence: A Retrospective Analysis of the ATAC Trial

(2011) AE Ring et al.   CANCER RESEARCH

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

(2011) Cornelis JH van de Velde et al.   LANCET

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

(2010) Tomohiko Aihara et al.   BREAST CANCER RESEARCH AND TREATMENT

Absolute Benefits of Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer: Should We Know More?

(2010) Bostjan Seruga et al.   JOURNAL OF CLINICAL ONCOLOGY

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

(2010) J. E. Garber et al.   JNCI-Journal of the National Cancer Institute

Tamoxifen: the drug that came in from the cold

(2009) L Hughes-Davies et al.   BRITISH JOURNAL OF CANCER

Up-Front Use of Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: The Emperor Has No Clothes

(2009) Bostjan Seruga et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials

(2008) Ruth Tsang et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial

(2008) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer

(2007) Federica Cuppone et al.   CANCER